These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 21410040)
1. Involvement of RhoGDI2 in the resistance of colon cancer cells to 5-fluorouracil. Zheng Z; Li J; He X; Chen X; Yu B; Ji J; Zhang J; Wang T; Gu Q; Zhu Z; Liu B Hepatogastroenterology; 2010; 57(102-103):1106-12. PubMed ID: 21410040 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846 [TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer. Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417 [TBL] [Abstract][Full Text] [Related]
4. [Screening and identification of genes associated with multi-drug resistance in colonic cancer]. Li JF; Zheng Z; Yu BQ; Qu Y; Zhu ZG; Liu BY Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Apr; 15(4):388-91. PubMed ID: 22539389 [TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of the basic proteins in 5-fluorouracil resistance of human colon cancer cell line using the radical-free and highly reducing method of two-dimensional polyacrylamide gel electrophoresis. Tanaka S; Sakai A; Kimura K; Yoshida H; Fushitani H; Ogata A; Miyamoto A; Fukushima M; Wada A; Tanigawa N Int J Oncol; 2008 Aug; 33(2):361-70. PubMed ID: 18636157 [TBL] [Abstract][Full Text] [Related]
6. Combining siRNAs at two different sites in the EGFR to suppress its expression, induce apoptosis, and enhance 5-fluorouracil sensitivity of colon cancer cells. Wu X; Deng Y; Wang G; Tao K J Surg Res; 2007 Mar; 138(1):56-63. PubMed ID: 17169374 [TBL] [Abstract][Full Text] [Related]
7. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells. Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433 [TBL] [Abstract][Full Text] [Related]
8. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil. Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123 [TBL] [Abstract][Full Text] [Related]
9. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells. Obama K; Kanai M; Kawai Y; Fukushima M; Takabayashi A Int J Oncol; 2002 Aug; 21(2):309-14. PubMed ID: 12118326 [TBL] [Abstract][Full Text] [Related]
10. Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78. Yun S; Han YS; Lee JH; Kim S; Lee SH Anticancer Res; 2017 Jun; 37(6):2975-2984. PubMed ID: 28551635 [TBL] [Abstract][Full Text] [Related]
11. Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer. Cho HJ; Baek KE; Kim IK; Park SM; Choi YL; Nam IK; Park SH; Im MJ; Yoo JM; Ryu KJ; Oh YT; Hong SC; Kwon OH; Kim JW; Lee CW; Yoo J J Proteome Res; 2012 Apr; 11(4):2355-64. PubMed ID: 22364609 [TBL] [Abstract][Full Text] [Related]
12. RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression. Cho HJ; Baek KE; Park SM; Kim IK; Nam IK; Choi YL; Park SH; Im MJ; Choi J; Ryu J; Kim JW; Lee CW; Kang SS; Yoo J Cancer Lett; 2011 Dec; 311(1):48-56. PubMed ID: 21752536 [TBL] [Abstract][Full Text] [Related]
13. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. De Angelis PM; Svendsrud DH; Kravik KL; Stokke T Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241 [TBL] [Abstract][Full Text] [Related]
14. Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line. Yoo BC; Jeon E; Hong SH; Shin YK; Chang HJ; Park JG Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4176-84. PubMed ID: 15217955 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Li J; Hou N; Faried A; Tsutsumi S; Takeuchi T; Kuwano H Ann Surg Oncol; 2009 Mar; 16(3):761-71. PubMed ID: 19116755 [TBL] [Abstract][Full Text] [Related]
16. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia. Wu Y; McRoberts K; Berr SS; Frierson HF; Conaway M; Theodorescu D Oncogene; 2007 Feb; 26(5):765-73. PubMed ID: 16878152 [TBL] [Abstract][Full Text] [Related]
17. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols. De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment. Yang SY; Miah A; Sales KM; Fuller B; Seifalian AM; Winslet M Int J Oncol; 2011 Jun; 38(6):1695-702. PubMed ID: 21424124 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment. Adamsen BL; Kravik KL; Clausen OP; De Angelis PM Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676 [TBL] [Abstract][Full Text] [Related]
20. Resistance of colorectal cancer cells to radiation and 5-FU is associated with MELK expression. Choi S; Ku JL Biochem Biophys Res Commun; 2011 Aug; 412(2):207-13. PubMed ID: 21806965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]